Related Experiment Video
Updated: May 26, 2026

07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
The oxazolidinones: past, present, and future
Karen Joy Shaw1, Michael R Barbachyn
1Trius Therapeutics, Inc., Department of Biology, San Diego, California 92121, USA. kshaw@triusrx.com
Annals of the New York Academy of Sciences
|December 24, 2011
Summary
New oxazolidinone antibiotics show promise for treating bacterial infections, with several in clinical trials. Challenges remain in overcoming resistance, particularly from the cfr gene.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Infectious Diseases
Background:
- The success of linezolid spurred the development of novel oxazolidinone antibiotics.
- Numerous oxazolidinones have entered clinical development, but many faced discontinuation due to suboptimal efficacy, pharmacokinetics, or safety concerns like myelosuppression.
Observation:
- Four oxazolidinones are currently in clinical evaluation for various infections.
- Tedizolid phosphate is the most advanced, in Phase 3 trials for skin infections.
- Radezolid, sutezolid, and AZD5847 are in earlier stages of clinical development for skin infections, pneumonia, and tuberculosis.
Findings:
- Oxazolidinones generally exhibit low resistance rates due to their mechanism targeting 23S ribosomal RNA.
- Maintaining potency against strains with the mobile cfr gene is a significant challenge for this class of antibiotics.
Implications:
- Continued research into oxazolidinones is crucial for addressing bacterial infections and combating antimicrobial resistance.
- Overcoming resistance mechanisms, such as those conferred by the cfr gene, is essential for the future clinical utility of oxazolidinones and other 50S ribosome inhibitors.
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para position.
Antibiotic Selection
Overview
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)